[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]
Tampilkan postingan dengan label Vienna. Tampilkan semua postingan
Tampilkan postingan dengan label Vienna. Tampilkan semua postingan
AIDS 2010 Conference Report Now Online
Read about the important developments presented during AIDS 2010 in the recently released AIDS 2010 Conference Report.
[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]
[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]
Still a long wait for HIV-approved protective gel
via South African Medical Journal, by Chris Bateman
June 2013 – that’s the ‘realistic’ date by which vulnerable South African women can expect to begin using an officially approved vaginal microbicide gel that would provide them with an unprecedented tool to protect themselves from HIV infection. This is the belief of biochemist and epidemiologist, Dr Quarraisha Abdool Karim, who, together with her clinician and fellow epidemiologist husband, Professor Salim Abdool Karim, led the now world-renowned ‘proof of concept’ trial of tenofovir vaginal gel to prevent HIV infection in women. In a 3-year study of 889 women in both rural and urban KwaZulu-Natal, they demonstrated a 39% reduction in HIV infection and a 51% reduction in genital herpes infection among women who used the gel (containing 1% of the antiretroviral (ARV), tenofovir).
Read more
To read even more on this subject see the IRMA blog from 7/27/10
June 2013 – that’s the ‘realistic’ date by which vulnerable South African women can expect to begin using an officially approved vaginal microbicide gel that would provide them with an unprecedented tool to protect themselves from HIV infection. This is the belief of biochemist and epidemiologist, Dr Quarraisha Abdool Karim, who, together with her clinician and fellow epidemiologist husband, Professor Salim Abdool Karim, led the now world-renowned ‘proof of concept’ trial of tenofovir vaginal gel to prevent HIV infection in women. In a 3-year study of 889 women in both rural and urban KwaZulu-Natal, they demonstrated a 39% reduction in HIV infection and a 51% reduction in genital herpes infection among women who used the gel (containing 1% of the antiretroviral (ARV), tenofovir).To read even more on this subject see the IRMA blog from 7/27/10
Straight Talk with Dr Zeda Rosenberg, CEO of the International Partnership for Microbicides
There were cheers and some tears at the International AIDS Conference in Vienna in July when delegates heard the news that a clinical trial in South Africa, had found a vaginal gel containing the antiretroviral drug, tenofovir, was 39 percent effective at reducing women's risk of contracting HIV during sex.
"There were tears from many people – tears of happiness that finally there is something we can work towards - and a lot of tears of sadness for all of the women whose lives have been lost waiting for a microbicide," Dr Zeda Rosenberg recalled at a recent meeting in Johannesburg, South Africa, hosted by the International Partnership for Microbicides (IPM), a non-profit organization.
IPM is involved in coordinating and funding the long process of developing effective microbicides - products that women can apply vaginally to protect themselves against HIV - and making sure they reach the women in developing countries who most need them. Rosenberg, who has been working in the field of HIV prevention research for more than two decades and is CEO of IPM, talked to IRIN/PlusNews after the meeting.
QUESTION: What do you think is the likelihood that women will use a microbicide any more consistently than men use condoms?
ANSWER: Part of the issue with condoms is that although they're highly effective, many people put a large value on skin-to-skin contact and ... in long-term relationships it just seems that condoms aren't used as often because it's a trust issue, an issue of intimacy; and also, if everyone uses a condom all the time, women can't get pregnant.
So there really does need to be a method that women can use where they and their partners don't feel it reduces intimacy, allows for conception, and is culturally acceptable.
I think microbicides need to be marketed with the message: 'Condoms should be used', because you don't want a less effective microbicide replacing highly effective condoms. At some point there will be all of these partially effective methods that, when used together, will be highly effective.
Adherence was a challenge in the [South African] trial - those women who reported greater adherence had greater efficacy. [The investigators] also saw a drop-off in product use over the course of the study, which means you need something that's sustainable in the long term.
For more click here.
BE HEARD! - Presentations Now Available from AIDS 2010 Event
Condoms Aren’t Enough!
Will Pills and Lubes Define the Future Of Sex?
Click 'n Learn right here!
More than 100 of the world's top experts on human rights and HIV among sexual minorities led presentations and workshops in Vienna on July 17 at BE HEARD, an all-day conference event that addressed soaring global rates of HIV among men who have sex with men (MSM). The event preceded the launch of AIDS 2010, the XVIII International AIDS Conference (IAC) and had nearly 600 participants.
IRMA was an event sponsor and Steering Committee members Ian McGowan, Jorge Sanchez, Roger Tatoud and Jim Pickett led a 2-hour session with other top researchers including Drs.Gaudensia Mutua, Jorge Saavedra and Patrick Wilson called "Condoms Aren’t Enough! Will Pills and Lubes Define the Future Of Sex? An Overview of New HIV Prevention Tools in Development."
Below are 5 of the presentations - please give each of them a click and learn. The first - directly below - begins with Dr. Mutua's talk - "Basic Concepts about AIDS Vaccine Research."
Hosted by the Global Forum on MSM & HIV (MSMGF), BE HEARD focused on challenges and solutions to achieving universal access to HIV-related prevention, care, treatment, and support services for sexual minority communities worldwide.
Will Pills and Lubes Define the Future Of Sex?
Click 'n Learn right here!
More than 100 of the world's top experts on human rights and HIV among sexual minorities led presentations and workshops in Vienna on July 17 at BE HEARD, an all-day conference event that addressed soaring global rates of HIV among men who have sex with men (MSM). The event preceded the launch of AIDS 2010, the XVIII International AIDS Conference (IAC) and had nearly 600 participants.
IRMA was an event sponsor and Steering Committee members Ian McGowan, Jorge Sanchez, Roger Tatoud and Jim Pickett led a 2-hour session with other top researchers including Drs.Gaudensia Mutua, Jorge Saavedra and Patrick Wilson called "Condoms Aren’t Enough! Will Pills and Lubes Define the Future Of Sex? An Overview of New HIV Prevention Tools in Development."
Below are 5 of the presentations - please give each of them a click and learn. The first - directly below - begins with Dr. Mutua's talk - "Basic Concepts about AIDS Vaccine Research."
Hosted by the Global Forum on MSM & HIV (MSMGF), BE HEARD focused on challenges and solutions to achieving universal access to HIV-related prevention, care, treatment, and support services for sexual minority communities worldwide.
HOT - IRMA pics from AIDS 2010
 |
| IRMA at AIDS 2010 |
Please feel free to include your AIDS 2010 snapshots right on Picasa, or send them to rectalmicro@gmail.com and we will add them for you. We'd love to include them in our collection.
Langganan:
Postingan (Atom)